MedPath

Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients

Not Applicable
Recruiting
Conditions
Hypertension
Arterial Stiffness
Registration Number
NCT07188272
Lead Sponsor
Deraya University
Brief Summary

Cardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and hypertension are closely related in pathophysiology. Chronic high blood pressure (BP) can lead to arterial wall damage by mechanical stress, endothelial dysfunction, increased inflammation, oxidative stress, and renin-angiotensin-aldosterone system (RAAS) activation. HIIT has been shown to be equally or even better at stimulating health benefits than moderate-intensity continuous training (MICT) and is considered a time-saving aerobic exercise for reducing arterial stiffness in HTN patients

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Their age< 35 up to 50 years old
  • Both sexes.
  • Controlled HTN ( stage 1,B.P 140-159 mmhg / 90-99 mmhg and stage 2, B.P 160-179 mmhg-100-109 mmhg )
  • Hemodynamic stable. Able to provide informed consent
Exclusion Criteria
  • Uncontrolled hypertension.
  • Severe HTN <180/110 mmhg
  • Renal dysfunction
  • Unstable cardiac conditions
  • Severe pulmonary disease that limit exercise
  • Impaired cognition
  • Musculoskeletal problems that made it difficult to do exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pulse Wave Velocityeach week

normal level 60-100 per minutes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Waleed Mohamed Abdelmohsen Abdelsalalm

🇪🇬

Minya, Egypt

Waleed Mohamed Abdelmohsen Abdelsalalm
🇪🇬Minya, Egypt
Soad A. Mohamad
Contact
01003621641
ph.soadali@yahoo.com
Waleed Mohamed Abdelmohsen Abdelsalalm, MSc
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.